Represión de Trump empuja a inmigrantes víctimas de violencia doméstica a las sombras
Línea de ayuda nacional para casos de violencia doméstica: Las personas que han sufrido abuso…
Represión de Trump empuja a inmigrantes víctimas de violencia doméstica a las sombras
Línea de ayuda nacional para casos de violencia doméstica: Las personas que han sufrido abuso doméstico pueden recibir ayuda confidencial en thehotline.org o llamando al 800-799-7233. La inmigrante originaria de India le creyó a su esposo cuando le dijo por teléfono que la mataría, si todavía estaba en su casa de Georgia para cuando él…
Conflicting Advice on Covid Shots Likely To Ding Already Low Vaccine Rates, Experts Warn
More than three-quarters of American adults didn’t get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations. The covid vaccine was initially popular. About 75% of Americans had received at least one dose of the first versions of the vaccine by early 2022,…
Listen: New Federal Guidelines Could Weaken Consumer Protections Against Medical Debt
LISTEN: Bad credit can keep you from getting a job, a car loan, or an apartment to rent. For many Americans, health care debt is to blame. KFF Health News senior correspondent Noam N. Levey appeared on WAMU’s “Health Hub” on Nov. 12 to explain why new federal guidelines on health care debt and credit…
KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use
About one in eight adults say that they are currently taking a GLP-1 drug either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern. Few adults think it is likely their prescription costs will go down as a result of…
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford
About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.
A Failure to Rescue: How Predictive Modeling Can Rewrite the Story of Congenital Syphilis
By KAYLA KELLY Every semester I have the privilege of guiding nursing students through their maternal and pediatric clinicals. At the beginning of the semester, their enthusiasm is contagious. They share stories about witnessing their first delivery, helping a new mother with breastfeeding, and practicing developmental assessments on pediatric patients. As the semester progresses, I…
MFN comes to Medicaid under the GENEROUS program
Last week, CMS announced the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) Model. The program basically is a ‘most favored nation’ style reference pricing based on net prices from developed countries. The program builds on the Medicaid Drug Rebate Program (MDRP). Specific details specified on the CMS website include: Participating manufacturers whose applications are accepted…
Despite Competition, All Big 4 Ambient Company CEOs Believe They Will Succeed
The CEOs of Nabla, Suki, Ambience Healthcare and Abridge separately spoke with MedCity News about why their products have staying power despite imminent competition from Epic. The post Despite Competition, All Big 4 Ambient Company CEOs Believe They Will Succeed appeared first on MedCity News.
Pluto Health, Help.AI Team Up to Advance Surgical Care
Pluto Health and Help.AI have partnered to integrate their platforms and use AI to streamline preoperative evaluations and improve surgical safety and efficiency. The post Pluto Health, Help.AI Team Up to Advance Surgical Care appeared first on MedCity News.
FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma
Kura Oncology’s Komzifti is approved for treating advanced cases of acute myeloid leukemia with an NPM1 mutation. A Syndax Pharmaceuticals drug is already approved in this indication, but Kura says its drug has advantages in safety and patient convenience. The post FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma appeared first…
